NCT04514471

Brief Summary

This open label, between-subject, randomized multi-center pilot study will assess the feasibility of conducting a study remotely with telehealth visits to assess the effect of cigarettes with minimal filter ventilation vs. moderate filter ventilation on smoking behavior and biomarkers of tobacco toxicant exposure. Subjective measures, alveolar carbon monoxide, blood pressure and cigarettes per a day will be collected remotely. Biological samples will be collected at home and mailed to the study clinic.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 12, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 17, 2020

Completed
3.6 years until next milestone

Study Start

First participant enrolled

March 18, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2025

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

January 12, 2026

Status Verified

January 1, 2026

Enrollment Period

1.2 years

First QC Date

August 12, 2020

Last Update Submit

January 8, 2026

Conditions

Outcome Measures

Primary Outcomes (3)

  • Feasibility of approach - Drop outs

    Percent of drop-outs in baseline and post-randomization.

    Baseline through Week 6

  • Feasibility of approach - Missing Data

    Extent (percent) of missing data

    Baseline through Week 6

  • Feasibility of approach - Participant Satisfaction

    Degree of difficulty collecting data through telehealth visits, mailing in biosamples and self-purchase of cigarettes (descriptive statistics (e.g., percent or mean responses)

    Baseline through Week 6

Secondary Outcomes (3)

  • Change in Total Nicotine Equivalents (TNE)

    effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference

  • Change in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)

    effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference

  • Change in mean cigarettes per day (CPD)

    effect size for each arm calculated as the baseline minus the 6 week value divided by the SD of this difference

Study Arms (2)

Unventilated Filter Cigarette

EXPERIMENTAL

Conventional cigarette with approximately 6-7% (non-menthol) and 5-6% filter ventilation (menthol).

Other: Unventilated filter cigarettes

Ventilated Filter Cigarette

ACTIVE COMPARATOR

Conventional cigarette with approximately 22-26% (non-menthol) and 35-38% filter ventilation (menthol).

Other: Ventilated filter cigarettes

Interventions

Currently marketed unventilated cigarettes

Unventilated Filter Cigarette

Currently marketed ventilated cigarettes

Ventilated Filter Cigarette

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • Regular cigarette smoker
  • Currently smoking an eligible brand
  • Generally good health
  • Access to smartphone or tablet and a device with a functioning camera for telehealth visits. Also must have internet access.

You may not qualify if:

  • Unstable health
  • Uncontrolled high blood pressure
  • Pregnant or breast-feeding

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Minnesota

Minneapolis, Minnesota, 55405, United States

Location

The Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

Location

MeSH Terms

Conditions

Tobacco Use

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Dorothy Hatsukami, PH.D

    Masonic Cancer Center, University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Open label, between-subject, randomized multi-center pilot study
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 12, 2020

First Posted

August 17, 2020

Study Start

March 18, 2024

Primary Completion

June 5, 2025

Study Completion

June 30, 2025

Last Updated

January 12, 2026

Record last verified: 2026-01

Locations